Humigent is an AI-native company transforming life sciences through applied AI. Built specifically for pharmaceutical and biotechnology organizations, Humigent combines deep industry expertise with cutting-edge AI to solve complex challenges and unlock growth opportunities. Its proprietary platform integrates a 30B-parameter vertical language model, specialized AI agents, and a life sciences-specific semantic layer, delivering accuracy, auditability, and enterprise interoperability.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/03/26 | undisclosed | Series A |
First Rays Venture Partners Z21 Ventures | undisclosed |